TOMASI, LUCIANA
TOMASI, LUCIANA
DIPARTIMENTO DI SCIENZE MEDICHE E CHIRURGICHE
Personale tecnico amm.vo
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease
2021 Salamon I.; Biagini E.; Kunderfranco P.; Roncarati R.; Ferracin M.; Taglieri N.; Nardi E.; Laprovitera N.; Tomasi L.; Santostefano M.; Ditaranto R.; Vitale G.; Cavarretta E.; Pisani A.; Riccio E.; Aiello V.; Capelli I.; La Manna G.; Galie N.; Spinelli L.; Condorelli G.
In vitro thrombogenicity of drug-eluting and bare metal stents
2020 Palmerini, Tullio; Barozzi, Chiara; Tomasi, Luciana; Riva, Diego Della; Marengo, Mario; Cicoria, Gianfranco; Bruno, Antonio G.; Bacchi-Reggiani, Maria-Letizia; Naldi, Marina; Bartolini, Manuela; Fanti, Stefano; Galiè, Nazzareno; Stone, Gregg W.
A Combined Targeted and Whole Exome Sequencing Approach Identified Novel Candidate Genes Involved in Heritable Pulmonary Arterial Hypertension
2019 Barozzi, Chiara; Galletti, Margherita; Tomasi, Luciana; De Fanti, Sara; Palazzini, Massimiliano; Manes, Alessandra; Sazzini, Marco; Galiè, Nazzareno
Effects of cardiac resynchronization therapy on right ventricular function during rest and exercise, as assessed by radionuclide angiography, and on NT-proBNP levels
2019 Valzania C.; Biffi M.; Bonfiglioli R.; Fallani F.; Martignani C.; Diemberger I.; Ziacchi M.; Frisoni J.; Tomasi L.; Fanti S.; Rapezzi C.; Boriani G.
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study
2014 Palmerini, T.; Calabro, P.; Piscione, F.; De Servi, S.; Cattaneo, M.; Maffeo, D.; Toso, A.; Bartorelli, A.; Palmieri, C.; De Carlo, M.; Capodanno, D.; Barozzi, C.; Tomasi, L.; Della Riva, D.; Mariani, A.; Taglieri, N.; Reggiani, L.B.; Bianchi, R.; De Rosa, R.; Mariani, M.; Podda, G.; Genereux, P.; Stone, G.W.; Angiolillo, D.J.
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction
2013 Palmerini, T; Tomasi, L; Barozzi, C; Della Riva, D; Mariani, A; Taglieri, N; Leone, O; Ceccarelli, C; Branzi, A; Ahamed, J (Ahamed
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction
2013 Tullio Palmerini;Luciana Tomasi;Chiara Barozzi;Diego Della Riva;Andrea Mariani;Nevio Taglieri;Ornella Leone;Claudio Ceccarelli;Stefano De Servi;Angelo Branzi;Philippe Genereux;Gregg W. Stone;Jasimuddin Ahamed
Residue depletion of sulphadiazine and trimethoprim in pigs and broilers after oral administration
2012 Roncada P.; Tomasi L.; Sori F.; Zaghini A.; Zaccaroni A.; Ferrara D.
A randomised study comparing the antiplatelet and antinflammatory effect of clopidogrel 150mg/day versus 75mg/day in patients with ST-segment elevation acute myocardial infarction and poor responsiveness to clopidogrel: Results from the DOUBLE study.
2010 Palmerini T; Barozzi C; Tomasi L; Sangiorgi D; Marzocchi A; De Servi S; Ortolani P; Bacchi Reggiani L; Alessi L; Lauria G; Bassi M; Branzi A.
A randomised comparison between clopidogrel 150 mg daily maintenance dose versus 75 mg in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention
2008 T. Palmerini; C. Barozzi; L. Tomasi; A. Marzocchi; C. Marrozzini; S. De Servi;D. Sangiorgi; L. Bacchi Reggiani; L. Alessi; G. Lauria; M. Bassi; A. Branzi
Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
2007 Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A.
Description of an In-vitro of Stent Perfusion to Study Stent Thrombosis at Different Shear Rates
2004 T.Palmerini; M.Marengo; V.Cervi; L.Tomasi; A.Marzocchi; C.Marozzini; s.Fabbri; P.Ortolani; O.Leone; M.Piccioli; D.Chiesa; P.Chieco; Romano Zannoli; A.Branzi.
Hydroxymethyl-glutaryl coenzyme a reductase inhibition limits cytomegalovirus infection in human endothelial cells.
2004 Potena L; Frascaroli G; Grigioni F; Lazzarotto T; Magnani G; Tomasi L; Coccolo F; Gabrielli L; Magelli C; Landini MP; Branzi A
Il trattamento intensivo della malattia paradontale riduce i markers sistemici di infiammazione ed ossidazione: studio prospettico su giovani pazienti con pregresso infarto miocardico.
2004 Melloni C; Tricoci PL; Melandri G; Montebugnoli L; Tomasi L; Guidorizzi G; Branzi A.
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system.
2004 Palmerini, T; Coller, Bs; Cervi, Vittorio; Tomasi, Luciana; Marzocchi, Antonio; Marrozzini, C; Leone, Ornella; Piccioli, M; Branzi, Angelo
Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system
2004 Palmerini T;Coller B;Cervi v; Tomasi L; Marzocchi A; Marrozzini C; Ortolani P; Branzi A
Ruolo del fattore tissutale circolante nel determinare la trombosi di stent in un sistema di perfusione in vitro.
2004 Palmerini T; Coller B; Cervi V; Tomasi L; Marzocchi A; Marrozzini C; Ortolani P; Leone O; Piccioli M; Marengo M; Chiesa D; Chieco P; Branzi A.